| Ytd | -9.72% | |
| 1y | 36.34% |
| Open | 6.04 | Prev Close | 6.04 | Low | 6.04 | High | 6.04 | Mkt Cap | 27.24M |
| Vol | 353.00 | Avg Vol | 23.60K | EPS | -0.36 | P/E | -16.78 | Forward P/E | 14.00 |
| Beta | 1.49 | Short Ratio | 2.66 | Inst. Own | 75.99% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-10 | 50-d Avg | 6.02 | 200-d Avg | 5.87 | 1yr Est | 6.25 |
HBIO News
On May 25, 2026, the Board of Directors (the "Board") of LENSAR, Inc. (the "Company"
Harvard Bioscience, Inc. (HBIO) Q1 2026 Earnings Call Transcript
First Quarter 2026 Revenues of $20.8M and Gross Margin of 59% Consolidation of Manufacturing Operati
HOLLISTON, Mass., May 07, 2026 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO) today ann
HOLLISTON, Mass., April 28, 2026 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO) will an
Harvard Bioscience (NASDAQ: HBIO) executives highlighted a year of "foundation building" and cost an
Harvard Bioscience, Inc. (HBIO) Q4 2025 Earnings Call Transcript
Fourth Quarter 2025 Revenues of $23.7M and Gross Margin of 59.7% Full Year 2025 Revenues of $86.6M a
Harvard Bioscience's common stock is expected to begin trading on a post-split adjusted basis on Mar
Harvard Bioscience, Inc. (NASDAQ: HBIO - Get Free Report)'s stock price passed above its two hundred
HOLLISTON, Mass., March 03, 2026 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO) today a
HOLLISTON, Mass., Feb. 26, 2026 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO) will ann
Shares of Harvard Bioscience, Inc. (NASDAQ: HBIO - Get Free Report) crossed below its 200-day moving
Reports preliminary fourth quarter revenue in line with guidance, gross margin at high end of guidan
Streamlining production footprint and improving manufacturing efficiency through phased closure of H
Completes Repayment of Existing Credit Agreement, Extends Debt Maturity, and Enhances Financial Flex
Harvard Bioscience, Inc. (NASDAQ: HBIO - Get Free Report) shares crossed above its two hundred day m
Former Treasury Secretary Larry Summers said he was stepping back from all public commitments amid f
Harvard Bioscience, Inc. ( HBIO ) Q3 2025 Earnings Call November 6, 2025 8:00 AM EST Company Partici
Reports Q3 2025 Revenues of $20.6M, Gross Margin of 58.4%, and Positive Cash Provided by Operations
HOLLISTON, Mass., Oct. 30, 2025 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO) will ann
Companies Reporting Before The Bell • CorEnergy Infr Tr (NYSE:CORR) is estimated to report earnings
Companies Reporting Before The Bell • Aurora Mobile (NASDAQ:JG) is expected to report earnings for
Monday saw 825 companies set new 52-week lows.